| Tender Number | 3622658 |
|---|---|
| Buyer | |
| Location | Multi city, Multi State |
| Awarded Value | ₹ 557,137 |
| Selected Bidder |
3 FDC with combination Isoniazid 75 mg and Rifampicin 150 mg and Ethambutol 275 mg Tab,4 FDC with combination Isoniazid 75 mg and Rifampicin 150 mg and Ethambutol 275 mg and Pyrazinamide 400 mg Tab,Amikacin Sulphate 250 mg per 2 ml Inj,Anti haemorhoidal Ointment containing Betamethasone 0.05 and Phenylephrine 0.1 and Lignocaine 2.5 tube of 15 gm with,Apixaban 5 mg Tab,Azelastine HCl 140 mcg and Fluticasone Propionate 50 mcg BP Nasal spray,B Complex Forte with Vitamin C Capsules,Bisacodyl 5 mg Tab,Chloramphenicol 5 percent and Clotrimazole 1 percent and Betamethasone 0.25 percent and Lignocaine HCl 2 percent bottle of 5ml,Cilnidipine 10mg Tab,Cinnarizine 25 mg Tab,Clotrimazole 1 percent and Lignocaine 2 percent ear drop bott of 10ml,Colchicine 0.5 mg Tab,Corn Cap,Cough Lozenges,Dapagliflozine 10 mg Tab,Desensitising paste Stannous Fluoride and Potassium Nitrate and Sodium monofluro phosphate Tube of 4055 ml or gm,Dexmedetomidine 100mcg per Ml of 2ml Inj,Dextromethorphan Hydrobromide and Chlorpheniramine Maleat
| AOC | Mon 1st September, 2025 |
|---|
| Document Name | Action |
|---|---|
| Tender Notice | Sign Up to Download |
Company Study
We evaluate your eligibility, strengths, certifications, and past performance to align with buyer requirements.
Competitor Analysis
We study likely bidders, past AOCs, pricing bands, and technical patterns to position your bid smartly.
Submission & JV Execution
We prepare compliant documents, set up JV agreements, and handle portal uploading end-to-end.
| # | Name | Value | Position | Status |
|---|---|---|---|---|
| 1 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 2 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 3 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 4 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 5 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 6 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 7 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 8 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 9 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 10 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 11 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 12 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 13 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 14 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 15 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 16 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 17 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 18 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 19 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 20 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 21 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 22 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 23 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 24 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |
| 25 | R.I. PHARAMACEUTICALS | 557137.30 | L1 | Qualified |
| 26 | AQUA PHARMA | 674643.30 | L2 | Qualified |
| 27 | ORBIT MEDI SOLUTIONS AND PHARMACEUTICAL DISTRIBUTORS | 775028.70 | L3 | Qualified |